KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables: 2009-2024

Historic Receivables for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $534.3 million.

  • Idexx Laboratories' Receivables rose 11.55% to $638.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 6.72%. This contributed to the annual value of $534.3 million for FY2024, which is 4.25% up from last year.
  • As of FY2024, Idexx Laboratories' Receivables stood at $534.3 million, which was up 4.25% from $512.6 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Receivables peaked at $534.3 million during FY2024, and registered a low of $355.3 million during FY2020.
  • Moreover, its 3-year median value for Receivables was $512.6 million (2023), whereas its average is $496.5 million.
  • Data for Idexx Laboratories' Receivables shows a peak YoY rose of 23.80% (in 2020) over the last 5 years.
  • Idexx Laboratories' Receivables (Yearly) stood at $355.3 million in 2020, then grew by 14.31% to $406.1 million in 2021, then climbed by 8.95% to $442.5 million in 2022, then grew by 15.84% to $512.6 million in 2023, then grew by 4.25% to $534.3 million in 2024.